t
Haleon PLC announced on 20 July 2022 the notification of transactions by four Persons Discharging Managerial Responsibilities (PDMRs). On 18 July 2022, CEO Brian McNamara, CDTO Amy Landucci, Head of Transformation and Sustainability Teri Lyng, and President North America Lisa Paley collectively received a total of 153,785 Haleon plc American Depositary Shares (ADSs) on the New York Stock Exchange, in accordance with the terms of the demerger from GSK.
| Date | 20 Jul 2022 |
| Time | 17:45:06 |
| Category | Director/PDMR dealings |
| ID | 2025T |
HALEON PLC
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
20 July 2022
Notification and Public Disclosure in accordance with the requirements of The EU Market Abuse Regulation of Transactions by Persons Discharging Managerial Responsibilities ("PDMR") and Persons Closely Associated with them.
On 18 July 2022, Haleon plc (the "Company") received notification of the following transaction as detailed below.
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
||||
|
a)
|
Name
|
Brian McNamara |
|||
|
2
|
Reason for the notification
|
||||
|
a)
|
Position/status
|
Chief Executive Officer - Person Discharging Managerial Responsibilities |
|||
|
b)
|
Initial notification /Amendment
|
Initial Notification |
|||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||
|
a)
|
Name
|
Haleon plc |
|||
|
b)
|
LEI
|
549300PSB3WWEODCUP19 |
|||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||||
|
a)
|
Description of the financial instrument, type of instrument |
Haleon plc American Depositary Shares (ADS) |
|||
|
|
|
||||
|
Identification code |
US405552100 |
||||
|
|
|
||||
|
b)
|
Nature of the transaction
|
ADSs received in the Company on 18 July 2022, in accordance with the terms of the demerger from GSK as disclosed in the Company's prospectus dated 1 June 2022.
|
|||
|
c)
|
Price(s) and volume(s) |
|
|
|
|
|
|
|
Price(s) |
Volume(s) |
|
|
|
|
|
n/a |
121,929 |
|
|
|
|
|
|
|
|
|
|
d)
|
Aggregated information |
|
|||
|
|
|
||||
|
- Aggregated volume |
121,929 |
||||
|
|
|
||||
|
- Price |
n/a |
||||
|
|
|
||||
|
e)
|
Date of the transaction
|
18 July 2022 |
|||
|
f)
|
Place of the transaction
|
New York Stock Exchange |
|||
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
||||
|
a)
|
Name
|
Amy Landucci |
|||
|
2
|
Reason for the notification
|
||||
|
a)
|
Position/status
|
Chief Digital and Technology Officer - Person Discharging Managerial Responsibilities |
|||
|
b)
|
Initial notification /Amendment
|
Initial Notification |
|||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||
|
a)
|
Name
|
Haleon plc |
|||
|
b)
|
LEI
|
549300PSB3WWEODCUP19 |
|||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||||
|
a)
|
Description of the financial instrument, type of instrument |
Haleon plc American Depositary Shares (ADS) |
|||
|
|
|
||||
|
Identification code |
US405552100 |
||||
|
|
|
||||
|
b)
|
Nature of the transaction
|
ADSs received in the Company on 18 July 2022, in accordance with the terms of the demerger from GSK as disclosed in the Company's prospectus dated 1 June 2022.
|
|||
|
c)
|
Price(s) and volume(s) |
|
|
|
|
|
|
|
Price(s) |
Volume(s) |
|
|
|
|
|
n/a |
5,681 |
|
|
|
|
|
|
|
|
|
|
d)
|
Aggregated information |
|
|||
|
|
|
||||
|
- Aggregated volume |
5,681 |
||||
|
|
|
||||
|
- Price |
n/a |
||||
|
|
|
||||
|
e)
|
Date of the transaction
|
18 July 2022 |
|||
|
f)
|
Place of the transaction
|
New York Stock Exchange |
|||
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
||||
|
a)
|
Name
|
Teri Lyng |
|||
|
2
|
Reason for the notification
|
||||
|
a)
|
Position/status
|
Head of Transformation and Sustainability - Person Discharging Managerial Responsibilities |
|||
|
b)
|
Initial notification /Amendment
|
Initial Notification |
|||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||
|
a)
|
Name
|
Haleon plc |
|||
|
b)
|
LEI
|
549300PSB3WWEODCUP19 |
|||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||||
|
a)
|
Description of the financial instrument, type of instrument |
Haleon plc American Depositary Shares (ADS) |
|||
|
|
|
||||
|
Identification code |
US405552100 |
||||
|
|
|
||||
|
b)
|
Nature of the transaction
|
ADSs received in the Company on 18 July 2022, in accordance with the terms of the demerger from GSK as disclosed in the Company's prospectus dated 1 June 2022.
|
|||
|
c)
|
Price(s) and volume(s) |
|
|
|
|
|
|
|
Price(s) |
Volume(s) |
|
|
|
|
|
n/a |
19,049 |
|
|
|
|
|
|
|
|
|
|
d)
|
Aggregated information |
|
|||
|
|
|
||||
|
- Aggregated volume |
19,049 |
||||
|
|
|
||||
|
- Price |
n/a |
||||
|
|
|
||||
|
e)
|
Date of the transaction
|
18 July 2022 |
|||
|
f)
|
Place of the transaction
|
New York Stock Exchange |
|||
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
||||
|
a)
|
Name
|
Lisa Paley |
|||
|
2
|
Reason for the notification
|
||||
|
a)
|
Position/status
|
President, North America - Person Discharging Managerial Responsibilities |
|||
|
b)
|
Initial notification /Amendment
|
Initial Notification |
|||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||
|
a)
|
Name
|
Haleon plc |
|||
|
b)
|
LEI
|
549300PSB3WWEODCUP19 |
|||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||||
|
a)
|
Description of the financial instrument, type of instrument |
Haleon plc American Depositary Shares (ADS) |
|||
|
|
|
||||
|
Identification code |
US405552100 |
||||
|
|
|
||||
|
b)
|
Nature of the transaction
|
ADSs received in the Company on 18 July 2022, in accordance with the terms of the demerger from GSK as disclosed in the Company's prospectus dated 1 June 2022.
|
|||
|
c)
|
Price(s) and volume(s) |
|
|
|
|
|
|
|
Price(s) |
Volume(s) |
|
|
|
|
|
n/a |
7,126 |
|
|
|
|
|
|
|
|
|
|
d)
|
Aggregated information |
|
|||
|
|
|
||||
|
- Aggregated volume |
7,126 |
||||
|
|
|
||||
|
- Price |
n/a |
||||
|
|
|
||||
|
e)
|
Date of the transaction
|
18 July 2022 |
|||
|
f)
|
Place of the transaction
|
New York Stock Exchange |
|||
Amanda Mellor
Company Secretary